Search NLS News

Gedea Biotech has been named Rapidus Company of the Year by a jury along with the Rapidus news agency, which monitors the strong growth industries in Skåne County and the Copenhagen area. The company ranked highest in strong competition with all of Skåne’s future hopefuls in fields ranging from technology to pharmaceuticals. Many highly successful […]

AstraZeneca has announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub. The new site will be a strategic R&D centre for AstraZeneca, as well as Alexion’s new corporate headquarters. The site will bring together approximately 1,500 R&D, commercial and corporate colleagues into a single purpose-built […]

Anki Malmborg Hager has extensive experience in the life sciences, including as a business developer and CEO of the Lund companies Cantargia, Diaprost, Senzagen and PainDrainer. “We’re thrilled to have an entrepreneur as experienced as Anki on our team. She has impressive credentials and unique insight into the challenges that startup companies face. Her background […]

Paolo Macchiarini who made headlines for pioneering surgery is charged with aggravated assault over procedure. Macchiarini has gone on trial in Sweden charged with aggravated assault, 11 years after he first performed experimental transplants of synthetic windpipes on patients. The trial centres on three transplants Macchiarini performed between 2011 and 2013, when a synthetic windpipe […]

Bio-Me has announced that Heiner Dreissman and Charles Stabell have been appointed as senior advisors. These steps are part of the company’s strategic plan to position Bio-Me as a leader in the field with its Precision Microbiome Profiling (PMP) platform which offers a targeted approach to microbiome analysis/profiling using state-of-the-art qPCR and are in advance […]

AstraZeneca’s Biologics License Application (BLA) for tremelimumab has been accepted for Priority Review in the US, supporting the indication of a single priming dose of the anti-CTLA4 antibody added to Imfinzi for the treatment of patients with unresectable hepatocellular carcinoma (HCC). A supplemental BLA (sBLA) has also been submitted for Imfinzi in this indication. This […]

The European Medicines Agency (EMA) has granted the company a positive scientific opinion for a proposed update to the storage conditions of two human insulins. EMA’s positive scientific opinion will now be used to support obtaining approval of the more flexible storage conditions by national health authorities in a number of relevant low- and middle-income […]

The company has submitted a request for an Orphan Drug Designation to the U.S. Food and Drug Administration (FDA) for the company’s development candidate XEN-D0501. The aim is to develop a novel treatment of a rare disease associated with pain due to neurogenic inflammation. “I’m really pleased, that we can now publically share what we […]

Ultimovacs has received a Notice of Allowance from the United States Patent and Trademarks Office (USPTO) concerning its US patent application on the use of vaccine-checkpoint inhibitor combinations to treat cancer. Subject to grant formalities, it is expected that a patent will issue with a patent term up to at least June 2037. Ultimovacs has […]

The Nobel Laureates in Medicine 2021 revealed the mechanisms that underpin the different sensations of temperature and touch. Their discoveries have led to a better understanding of how the nervous system codes sensory information, as well as triggering a myriad of exciting new questions. Since the 1940s, it has been demonstrated that nerve cells are […]